quinazolines has been researched along with antimony in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Patterson, TJ; Rice, RH | 1 |
Dujardin, JC; Kyle, DE; Manetsch, R; Pandharkar, T; Rijal, S; Van Horn, KS; Vanaerschot, M; Vesely, B; Wang, MZ; Werbovetz, KA; Yang, S; Zhu, X | 1 |
2 other study(ies) available for quinazolines and antimony
Article | Year |
---|---|
Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential.
Topics: Antimony; Arsenites; beta Catenin; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Cell Line, Transformed; Cell Proliferation; Cells, Cultured; Cycloheximide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gene Expression; Humans; Insulin; Keratinocytes; Male; Matrix Metalloproteinase 7; PPAR delta; Pyrimidines; Quinazolines; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tyrphostins | 2007 |
Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.
Topics: Animals; Antimony; Cell Line; Diamines; Drug Resistance; Leishmania; Leishmania donovani; Leishmania mexicana; Leishmaniasis, Visceral; Macrophages; Male; Mice, Inbred BALB C; Quinazolines; Structure-Activity Relationship; Trypanocidal Agents | 2014 |